Let me chime in again. I plan to leave this forum for good after this post, primarily because I am retiring on June 23, my 65th birthday.
I have taken notice of what is going on with the iHub crowd and I craft this post because there would be a standing ovation if Mr. Berman left DECN, and along with the other professional director Mr. Lyons. So I crafted a list of actions the new/replacement CEO would/could do upon Mr. Berman's exit. I think there would be many posters here who would also be ecstatic. After all we are all only interested in share price. So with that, let there be light.
I agree Mr. Berman must go. And he should be replaced with a person who is single so message board posters would not have wives/husbands and children to attack in public forums. The new CEO should not have wealthy friends who could/would buy large blocks of stock, only to be attacked by name by message board posters. Nonetheless, let me outline what the new CEO would face.
On his first day on the job the new CEO can bring an end to all capital raising activities because of the dilution effect. Dilution is this company's death knell and it HAS to end.
On his second day on the job the new CEO can bring an end to the J&J lawsuit because it costs money to prosecute a lawsuit and the new CEO would have ended all capital raising activities the day before. Further the new CEO would not be not an engineer, because engineers are almost always fully employed (I certainly have been for 42 years) and there would not be enough capital to pay an engineer to be CEO, nor would the new CEO have experience with in-vitro diagnostics products, because in-vitro guys are very, very expensive and very, very employed. For example there would not be enough money to make a guy like me leave my employer to take on the DECN position if offered. So going after J&J for what they did to GenUltimate and GenStrip would be a waste. On the litigation end, after his departure, Mr. Berman would have to be replaced with a full time internal expert working directly for the lawyers. Experts are even more expensive and they almost always carry no business experience. But, instead the new CEO can settle the lawsuit as an alternative, but he would have to make sure that the settlement spoils would be distributed to loyal shareholders. Or else.
On his third day on the job the new CEO should bring an end to new products development. New products development costs money and he/she would have ended all capital raising, and new products could no longer be paid for, but think of all the money that would be saved by not having to market the new products that the company just ended the development of. And there would not be a need for a rookie CEO to battle the FDA from the usual disadvantages. Or take a small amount of that money and invest it in stock price management. That would be extremely popular with the penny stock trading crowd.
On the fourth day on the job, the new CEO would have to take an axe to the company staff. That would be a very popular move because message board posters don't think a lot of them anyway. It would also save money especially as the company's focus transits to stock price management.
On the fifth day on the job the new CEO should reorder manufacturing. There would no longer be a need for two manufacturers because there would be no new products in the pipeline. So, one would have to go. I would recommend that the Koreans be fired because everyone knows they are corrupt and Mr. Berman is parking company money in Korea to be used for himself. I have read that 50 times if I have read that once, so it must be true. The new CEO could get all of that money back.
On the sixth day on the job the new CEO could reorganize the BOD replacing the remaining two in-vitro diagnostics pros (Mr. Berman and Mr. Lyons) with stock traders. The company's BOD could look similar to TAUG's BOD. Two stock jockeys and a flailing CEO who's strings are being pulled by a corrupt consultant. These actions would allow the new CEO to spend 24/7 on the DECN stock price, and a merger with a shell. Or, the new CEO could spend what little resources that are remaining to bring the company another action following TAUG's lead. Look how well this has all worked out for them.
On the seventh day on the job the new CEO could rest. And good luck to us all. The misery, in my opinion, would not last long.
I have taken notice of what is going on with the iHub crowd and I craft this post because there would be a standing ovation if Mr. Berman left DECN, and along with the other professional director Mr. Lyons. So I crafted a list of actions the new/replacement CEO would/could do upon Mr. Berman's exit. I think there would be many posters here who would also be ecstatic. After all we are all only interested in share price. So with that, let there be light.
I agree Mr. Berman must go. And he should be replaced with a person who is single so message board posters would not have wives/husbands and children to attack in public forums. The new CEO should not have wealthy friends who could/would buy large blocks of stock, only to be attacked by name by message board posters. Nonetheless, let me outline what the new CEO would face.
On his first day on the job the new CEO can bring an end to all capital raising activities because of the dilution effect. Dilution is this company's death knell and it HAS to end.
On his second day on the job the new CEO can bring an end to the J&J lawsuit because it costs money to prosecute a lawsuit and the new CEO would have ended all capital raising activities the day before. Further the new CEO would not be not an engineer, because engineers are almost always fully employed (I certainly have been for 42 years) and there would not be enough capital to pay an engineer to be CEO, nor would the new CEO have experience with in-vitro diagnostics products, because in-vitro guys are very, very expensive and very, very employed. For example there would not be enough money to make a guy like me leave my employer to take on the DECN position if offered. So going after J&J for what they did to GenUltimate and GenStrip would be a waste. On the litigation end, after his departure, Mr. Berman would have to be replaced with a full time internal expert working directly for the lawyers. Experts are even more expensive and they almost always carry no business experience. But, instead the new CEO can settle the lawsuit as an alternative, but he would have to make sure that the settlement spoils would be distributed to loyal shareholders. Or else.
On his third day on the job the new CEO should bring an end to new products development. New products development costs money and he/she would have ended all capital raising, and new products could no longer be paid for, but think of all the money that would be saved by not having to market the new products that the company just ended the development of. And there would not be a need for a rookie CEO to battle the FDA from the usual disadvantages. Or take a small amount of that money and invest it in stock price management. That would be extremely popular with the penny stock trading crowd.
On the fourth day on the job, the new CEO would have to take an axe to the company staff. That would be a very popular move because message board posters don't think a lot of them anyway. It would also save money especially as the company's focus transits to stock price management.
On the fifth day on the job the new CEO should reorder manufacturing. There would no longer be a need for two manufacturers because there would be no new products in the pipeline. So, one would have to go. I would recommend that the Koreans be fired because everyone knows they are corrupt and Mr. Berman is parking company money in Korea to be used for himself. I have read that 50 times if I have read that once, so it must be true. The new CEO could get all of that money back.
On the sixth day on the job the new CEO could reorganize the BOD replacing the remaining two in-vitro diagnostics pros (Mr. Berman and Mr. Lyons) with stock traders. The company's BOD could look similar to TAUG's BOD. Two stock jockeys and a flailing CEO who's strings are being pulled by a corrupt consultant. These actions would allow the new CEO to spend 24/7 on the DECN stock price, and a merger with a shell. Or, the new CEO could spend what little resources that are remaining to bring the company another action following TAUG's lead. Look how well this has all worked out for them.
On the seventh day on the job the new CEO could rest. And good luck to us all. The misery, in my opinion, would not last long.
3
1
